ROTELLA, CARLO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 16.510
EU - Europa 10.539
AS - Asia 5.639
SA - Sud America 721
AF - Africa 176
OC - Oceania 150
Continente sconosciuto - Info sul continente non disponibili 122
Totale 33.857
Nazione #
US - Stati Uniti d'America 16.299
RU - Federazione Russa 3.012
IT - Italia 2.258
PL - Polonia 1.958
SG - Singapore 1.682
CN - Cina 1.203
HK - Hong Kong 907
IE - Irlanda 822
SE - Svezia 738
VN - Vietnam 656
BR - Brasile 603
KR - Corea 461
DE - Germania 359
UA - Ucraina 342
FR - Francia 297
FI - Finlandia 276
IN - India 206
GB - Regno Unito 186
AU - Australia 148
CA - Canada 134
JO - Giordania 108
NL - Olanda 92
CH - Svizzera 88
TR - Turchia 69
BD - Bangladesh 53
ID - Indonesia 51
JP - Giappone 48
CI - Costa d'Avorio 47
IQ - Iraq 41
AR - Argentina 40
MX - Messico 31
NG - Nigeria 30
ES - Italia 25
ZA - Sudafrica 25
AT - Austria 21
PK - Pakistan 21
EC - Ecuador 20
SC - Seychelles 17
BE - Belgio 16
CO - Colombia 16
MA - Marocco 15
UZ - Uzbekistan 15
VE - Venezuela 14
TW - Taiwan 12
IR - Iran 10
NP - Nepal 10
PH - Filippine 10
CL - Cile 9
JM - Giamaica 9
SA - Arabia Saudita 9
DZ - Algeria 8
EG - Egitto 8
HN - Honduras 8
KE - Kenya 8
PT - Portogallo 8
TN - Tunisia 8
AM - Armenia 7
IL - Israele 7
LT - Lituania 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
GT - Guatemala 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
LB - Libano 5
MM - Myanmar 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AL - Albania 4
KZ - Kazakistan 4
PE - Perù 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
GR - Grecia 3
MD - Moldavia 3
PA - Panama 3
SY - Repubblica araba siriana 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
LV - Lettonia 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BB - Barbados 1
Totale 33.722
Città #
Santa Clara 2.556
Warsaw 1.957
Fairfield 1.695
Ashburn 1.688
Singapore 1.174
Chandler 935
Dublin 821
Seattle 755
Woodbridge 751
Hong Kong 716
Cambridge 713
Wilmington 598
Houston 591
Jacksonville 544
Seoul 459
Milan 423
Beijing 340
San Jose 331
Dallas 283
Ann Arbor 268
Council Bluffs 261
Princeton 245
Los Angeles 236
Buffalo 234
Rome 217
Ho Chi Minh City 203
Altamura 201
Lawrence 191
The Dalles 189
Lauterbourg 187
Hanoi 158
Florence 153
Melbourne 142
Boston 140
Mumbai 131
Boardman 129
Hefei 122
Medford 118
New York 116
San Diego 98
Bern 82
Moscow 79
Munich 71
Shanghai 65
Naples 60
Paris 55
Kent 49
Helsinki 48
Abidjan 47
Izmir 46
São Paulo 46
Tokyo 43
Turin 41
Frankfurt am Main 40
Norwalk 40
Figino 38
Bologna 37
Phoenix 33
Dong Ket 32
Falls Church 32
Clifton 31
Redondo Beach 31
Andover 28
Bari 28
Orem 28
Jakarta 27
Abuja 26
Haiphong 26
Chicago 25
Montreal 25
Palermo 24
Brooklyn 23
London 23
San Francisco 22
Toronto 22
Columbus 21
Hillsboro 21
Venice 21
Verona 21
Vienna 21
Da Nang 20
Genoa 20
Chennai 17
Frankfurt Am Main 17
Tianjin 17
Turku 17
Brussels 16
Denver 16
Miano 16
Atlanta 15
Baghdad 15
Catania 15
Stockholm 15
Brasília 14
Brescia 14
Guangzhou 14
Rio de Janeiro 14
Taranto 14
Auburn Hills 13
Belo Horizonte 13
Totale 22.859
Nome #
The Florence Emotional Eating Drive (FEED): a validation study of a self-report questionnaire for emotional eating 425
Cystatin C reference values and aging 418
Adipokines as possible new predictors of cardiovascular diseases: a case control study. 351
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 324
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 323
Present and future association between obesity and hypogonadism in Italian male 321
Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study). 318
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. 299
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. 297
Diagnostic Crossover and Outcome Predictors in Eating Disorders According to DSM-IV and DSM-V Proposed Criteria: A 6-Year Follow-Up Study. 286
Clinical and psychological correlates of health-related quality of life in obese patients. 282
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 278
Inflammatory mediators, obesity and type 2 diabetes stimulate adhesion of human dendritic cells to coronary smooth muscle cells. 276
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes 274
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 273
Quality of life and overweight: the obesity related well-being (Orwell 97) questionnaire 260
A case of malignant insulinoma responsive to somatostatin analogs treatment 255
The therapy of insulin resistance in other diseases besides type 2 diabetes. 242
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 242
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A) 239
5-HT2A receptor gene polymorphism and eating disorders. 233
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 229
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 225
Assessment of psychological predictors of weight loss: How and what for? 224
Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular Disease 220
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 218
Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. 211
Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. 209
Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1) 209
Adherence to structured physical exercise in overweight and obese subjects: A review of psychological models 208
Amphetamine derivatives and obesity 203
5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa 201
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 198
Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells 196
Correlations between binge eating and emotional eating in a sample of overweight subjects 195
Different moderators of cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eating disorder: a three-year follow-up study. 195
Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes 195
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 195
Comparison of individual and group cognitive behavioral therapy for binge eating disorder. A randomized, three-year follow-up study. 195
Aggressiveness, Anger and Eating Disorders: a Review. 191
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 190
5-HT2A promoter polymorphism in anorexia nervosa. 190
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. 188
Different distribution of phenotypes and glucose tolerance categories associated with two alternative proposed cutoffs of insulin resistance. 186
Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes 185
Sexual Function in Obese Women with and without Binge EatingDisorder. 185
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 185
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 183
Lipid and protein oxidation products,antioxidant status and vascular complications in poorly controlled type 2 diabetes 183
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 181
Psychopathological similarities and differences between obese patients seeking surgical and non-surgical overweight treatments 181
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 181
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 180
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 178
Comparison between normal-weight and overweight bulimic patients. 178
Group versus individual cognitive-behavioral treatment for obesity: Results after 36 months 177
Parathyroid hormone bioassay using human kidney cortical cells in primary culture. 176
Clinical approach to diabetic cardiomyopathy: A review of human studies 176
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 175
Catecholamine, vasoactive intestinal peptide and thyrotrophin-dependent cAMP levels display a different sensitivity to iodothyronines in both normal and pathological human thyroid cells in culture. 173
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 173
SEX STEROIDS AND ODORANTS MODULATE GONADOTROPIN-RELEASING HORMONE SECRETION IN PRIMARY CULTURES OF HUMAN OLFACTORY CELLS. 173
Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. 172
A link between hyperlipidemia and lithium? Confirmation of a recent previous observation. 172
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. 172
Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. 172
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 171
EFFECTS OF INSULIN AND GLUCOSE ON THE GROWTH AND THE RELEASE OF EXTRACELLULAR-MATRIX COMPONENTS BY BOVINE BONE ENDOTHELIAL-CELLS 170
Screening for Binge Eating Disorder in obese outpatients. 170
Cholinergic control of cyclic nucleotide metabolism in human thyroid cells. 170
Lipid accumulation product and 25-OH-vitamin D deficiency in type 2 diabetes 169
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 169
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 167
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 167
Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications 167
Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells. 166
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 166
Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes. 166
Hyperparathyroidim: Is It Really the Major Factor Affecting Glucose Tolerance in Uremia. 165
Role of insulin in the type 2 diabetes therapy: past, present and future. 165
Anorexia Nervosa and Celial Disease: two case report. 164
All roads bring to Rome: a different way for predicting success in the therapy of obesity through psychological features 164
Bone: incretin hormones perceiver or receiver? 163
Salmon calcitonin and cGMP production by human kidney: studies in vivo and in vitro. 163
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 162
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. 160
Human calcitonin increases both cyclic AMP and cyclic GMP accumulation in human kidney cells. 160
Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa. 159
Loss of adrenergic regulation of cAMP production in the FRTL-5 cell line. 158
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 158
Eating disorders in patients with type 1 diabetes: a meta-analysis. 158
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. 157
Orlistat and sibutramine beyond weight loss 155
Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. 155
Meccanismi infiammatori regolano le interazioni tra cellule muscolari coronariche lisce e cellule dendritiche umane 153
Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients. 153
Forskolin perturbs cGMP as well as cAMP levels in human thyroid cells. 153
Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. 152
Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control 152
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. 152
Totale 20.297
Categoria #
all - tutte 90.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.236 0 0 93 59 59 58 52 83 81 53 282 416
2022/20233.735 398 601 116 339 265 722 446 183 426 29 92 118
2023/20241.233 62 167 225 59 67 170 48 237 19 39 72 68
2024/20258.151 336 956 591 1.277 2.333 941 117 473 415 249 271 192
2025/20268.800 963 1.177 684 449 939 345 1.123 479 556 520 185 1.380
2026/2027788 479 301 8 0 0 0 0 0 0 0 0 0
Totale 33.857